- |||||||||| Toujeo (Long-acting Recombinant Human Insulin Analogue) / Sanofi, Lantus (insulin glargine) / Sanofi, Levemir (insulin detemir rDNA origin) / Novo Nordisk
Enrollment closed: Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics (clinicaltrials.gov) - Nov 2, 2016 P=N/A, N=100000, Active, not recruiting, Trial primary completion date: Sep 2015 --> Mar 2017 Enrolling by invitation --> Active, not recruiting
- |||||||||| Byetta (exenatide) / AstraZeneca
Trial primary completion date: New Onset Type 1 Diabetes: Role of Exenatide (clinicaltrials.gov) - Jan 17, 2016 P4, N=20, Recruiting, Trial primary completion date: Dec 2015 --> Mar 2016 Trial primary completion date: Dec 2015 --> Dec 2017
- |||||||||| Lantus (insulin glargine) / Sanofi, Levemir (insulin detemir rDNA origin) / Novo Nordisk, NovoLog (insulin aspart) / Novo Nordisk
Enrollment closed, Trial primary completion date: Study of Glycemic Control on Liver Transplantation Outcomes (clinicaltrials.gov) - Oct 8, 2015 P4, N=164, Active, not recruiting, Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Dec 2015
- |||||||||| Levemir (insulin detemir rDNA origin) / Novo Nordisk
Enrollment change: Detemir: Role in Type 1 Diabetes (clinicaltrials.gov) - Sep 14, 2015 P4, N=13, Completed, Trial primary completion date: Mar 2015 --> Dec 2015 N=20 --> 13
- |||||||||| Levemir (insulin detemir rDNA origin) / Novo Nordisk
Enrollment closed, Trial primary completion date: IDIOM: Insulin Detemir in Obesity Management (clinicaltrials.gov) - Jun 25, 2015 P=N/A, N=240, Active, not recruiting, Trial primary completion date: Oct 2014 --> Oct 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2013 --> Dec 2015
- |||||||||| Byetta (exenatide) / AstraZeneca
Trial primary completion date: New Onset Type 1 Diabetes: Role of Exenatide (clinicaltrials.gov) - Jun 23, 2015 P4, N=20, Recruiting, Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2013 --> Dec 2015 Trial primary completion date: Dec 2014 --> Dec 2015
|